Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.

Autor: van Leeuwen M; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.v.leeuwen@nki.nl., Kieffer JM; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Young TE; Lynda Jackson Macmillan Centre, North Hertfordshire NHS Trust Including Mount Vernon Cancer Centre, East &, Northwood, UK., Annunziata MA; Unit of Oncological Psychology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Arndt V; Unit of Cancer Survivorship Research, Division of Clinical Epidemiology and Aging Research & Epidemiological Cancer Registry Baden-Wurttemberg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Arraras JI; Oncology Departments, Complejo Hospitalario de Navarra, Pamplona, Spain., Autran D; Pole Neurosciences Cliniques, Service de Neuro-Oncologie, Aix-Marseille Universite, Marseille, France., Hani HB; King Hussein Cancer Center, Amman, Jordan., Chakrabarti M; Columbia Asia Hospital, Kolkata, India., Chinot O; Pole Neurosciences Cliniques, Service de Neuro-Oncologie, Aix-Marseille Universite, Marseille, France., Cho J; Center for Clinical Epidemiology and Cancer Education Center, Samsung Medical Center, School of Medicine Sungkyunkwan University, Seoul, Korea., da Costa Vieira RA; Postgraduate Program in Oncology, Barretos Cancer Hospital, Sao Paulo, Barretos, Brazil., Darlington AS; School of Health Sciences, University of Southampton, Southampton, UK., Debruyne PR; Kortrijk Cancer Centre, General Hospital Groeninge, Kortrijk, Belgium., Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Doege D; Unit of Cancer Survivorship Research, Division of Clinical Epidemiology and Aging Research & Epidemiological Cancer Registry Baden-Wurttemberg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Eller Y; Centre for Medical Education, University of Dundee, Dundee, UK., Eichler M; National Center for Tumor Diseases (NCT/UCC), University Hospital Carl Gustav Carus Dresden, Dresden, Germany., Fridriksdottir N; National University Hospital of Iceland, Ugo De Giorgi, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, 47014, Italy., Gioulbasanis I; Chemotherapy Department, Larissa General Clinic 'E Patsidis', Athens, Greece., Hammerlid E; Department of Otolaryngology, Head and Neck Surgery, Sahlgrenska University Hospital, Goteborg, Sweden., van Hemelrijck M; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Hermann S; Epidemiological Cancer Registry Baden-Wurttemberg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Husson O; Division of Clinical Studies, Institute of Cancer Research, London, UK., Jefford M; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Johansen C; Oncology Clinic, Finsen Center, Copenhagen Colin Johnson, University Surgical Unit, University Hospitals Southampton, Southampton, UK., Kjaer TK; Survivorship and Inequality in Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark., Kontogianni M; Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece., Lagergren P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Lidington E; The Royal Marsden NHS Foundation Trust, London, UK., Lisy K; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Morag O; Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel., Nordin A; East Kent Gynaecological Oncology Centre, Margate, UK., Al Omari ASH; King Hussein Cancer Center, Amman, Jordan., Pace A; Neuroncology Unit, National Cancer Institute Regina Elena, Rome, Italy., De Padova S; Psycho-Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, 47014, Italy., Petranovia D; Hematology Department, University Clinical Hospital Center Rijeka, Medical Faculty University of Rijeka, Rijeka, Croatia., Pinto M; Rehabilitation Medicine Unit, Department of Strategic Health Services, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy., Ramage J; Department of Gastroenterology and Hepatology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK., Rammant E; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Reijneveld J; Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Serpentini S; Unit of Psychoncology-Breast Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy., Sodergren S; School of Health Sciences, University of Southampton, Southampton, UK., Vassiliou V; Department of Radiation Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus., Leeuw IV; Department of Otolaryngology / Head & Neck Surgery, Amsterdam UMC, Amsterdam, The Netherlands., Vistad I; Department of Gynecology and Obstetrics, Sorlandet Hospital Kristiansand, Kristiansand, Norway., Young T; Lynda Jackson Macmillan Centre, Mount Vernon Cancer Centre, Northwood, UK., Aaronson NK; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van de Poll-Franse LV; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Publikováno v: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2023 Aug; Vol. 17 (4), pp. 1111-1130. Date of Electronic Publication: 2022 Jan 27.